Slow releasing sulphide donor GYY4137 protects mice against ventilator-induced lung injury.

IF 2.8 Q2 CRITICAL CARE MEDICINE
Lilly Veskemaa, Mahdi Taher, Jan Adriaan Graw, Adrian Gonzalez-Lopez, Roland C E Francis
{"title":"Slow releasing sulphide donor GYY4137 protects mice against ventilator-induced lung injury.","authors":"Lilly Veskemaa, Mahdi Taher, Jan Adriaan Graw, Adrian Gonzalez-Lopez, Roland C E Francis","doi":"10.1186/s40635-025-00753-9","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Cyclic stretching of the lung during mechanical ventilation induces inflammation that contributes to the development of ventilator induced lung injury. Hydrogen sulphide (H<sub>2</sub>S) is an endogenous gasotransmitter known for its anti-inflammatory properties. However, the administration of exogenous H<sub>2</sub>S is constrained by its narrow therapeutic window, rapidly leading to potentially toxic peak concentrations. Alternatively, slow-release sulphide donors, such as GYY4137, offer a more controlled delivery. The primary aim of this study is to assess the efficacy and safety of GYY4137 in mitigating VILI.</p><p><strong>Methods: </strong>Anaesthetised male C57BL/6 J mice were pretreated with an intraperitoneal injection of GYY4137 (50 mg/kg, n = 14) or an equivalent volume of phosphate-buffered saline (controls, n = 13) and were then subjected to high tidal volume ventilation (V<sub>T</sub> 40-42.5 ml/kg) for a maximum of 4 h.</p><p><strong>Results: </strong>GYY4137 pretreatment led to a notable 50% increase in survival rates compared to controls (p = 0.0025). It also improved arterial oxygenation after high V<sub>T</sub> ventilation, with arterial partial pressure of oxygen (PaO2) of 64 mmHg (IQR 49-125 mmHg) vs. 44 mmHg (IQR 42-51 mmHg) in controls (p < 0.001). Additionally, GYY4137 reduced total protein concentration in bronchoalveolar lavage fluid by 30% (p = 0.024) and lowered IL-1β levels by 40% (p = 0.006). GYY4137 mitigated the decline in dynamic respiratory system compliance caused by high V<sub>T</sub> ventilation, showing values of 24 μl/cmH<sub>2</sub>O (IQR 22-27) compared to 22 μl/cmH<sub>2</sub>O (IQR 22-24) in controls (p = 0.017). GYY4137 had minimal effects on antioxidant gene expression related to the erythroid nuclear factor 2, and it did not affect glutathione metabolism, the nuclear factor kappa B pathway, or the endoplasmic reticulum stress response.</p><p><strong>Conclusions: </strong>In this mouse model of VILI, pretreatment with GYY4137 showed protective effects. GYY4137 significantly improved survival. It also improved arterial blood oxygenation and dynamic respiratory system compliance, and mitigated the development of lung oedema and inflammation.</p>","PeriodicalId":13750,"journal":{"name":"Intensive Care Medicine Experimental","volume":"13 1","pages":"45"},"PeriodicalIF":2.8000,"publicationDate":"2025-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12014871/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Intensive Care Medicine Experimental","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s40635-025-00753-9","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CRITICAL CARE MEDICINE","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Cyclic stretching of the lung during mechanical ventilation induces inflammation that contributes to the development of ventilator induced lung injury. Hydrogen sulphide (H2S) is an endogenous gasotransmitter known for its anti-inflammatory properties. However, the administration of exogenous H2S is constrained by its narrow therapeutic window, rapidly leading to potentially toxic peak concentrations. Alternatively, slow-release sulphide donors, such as GYY4137, offer a more controlled delivery. The primary aim of this study is to assess the efficacy and safety of GYY4137 in mitigating VILI.

Methods: Anaesthetised male C57BL/6 J mice were pretreated with an intraperitoneal injection of GYY4137 (50 mg/kg, n = 14) or an equivalent volume of phosphate-buffered saline (controls, n = 13) and were then subjected to high tidal volume ventilation (VT 40-42.5 ml/kg) for a maximum of 4 h.

Results: GYY4137 pretreatment led to a notable 50% increase in survival rates compared to controls (p = 0.0025). It also improved arterial oxygenation after high VT ventilation, with arterial partial pressure of oxygen (PaO2) of 64 mmHg (IQR 49-125 mmHg) vs. 44 mmHg (IQR 42-51 mmHg) in controls (p < 0.001). Additionally, GYY4137 reduced total protein concentration in bronchoalveolar lavage fluid by 30% (p = 0.024) and lowered IL-1β levels by 40% (p = 0.006). GYY4137 mitigated the decline in dynamic respiratory system compliance caused by high VT ventilation, showing values of 24 μl/cmH2O (IQR 22-27) compared to 22 μl/cmH2O (IQR 22-24) in controls (p = 0.017). GYY4137 had minimal effects on antioxidant gene expression related to the erythroid nuclear factor 2, and it did not affect glutathione metabolism, the nuclear factor kappa B pathway, or the endoplasmic reticulum stress response.

Conclusions: In this mouse model of VILI, pretreatment with GYY4137 showed protective effects. GYY4137 significantly improved survival. It also improved arterial blood oxygenation and dynamic respiratory system compliance, and mitigated the development of lung oedema and inflammation.

缓释硫化物供体GYY4137对呼吸机诱导的小鼠肺损伤具有保护作用。
背景:机械通气时肺的周期性伸展可引起炎症,从而促进呼吸机性肺损伤的发展。硫化氢(H2S)是一种内源性气体递质,以其抗炎特性而闻名。然而,外源性H2S的施用受到其狭窄的治疗窗口的限制,迅速导致潜在的毒性峰值浓度。另外,缓慢释放的硫化物供体,如GYY4137,提供更可控的输送。本研究的主要目的是评估GYY4137缓解VILI的有效性和安全性。方法:雄性C57BL/6 J小鼠麻醉后,先腹腔注射GYY4137 (50 mg/kg, n = 14)或等量的磷酸盐缓冲生理盐水(对照组,n = 13),然后进行高潮气量通气(VT 40-42.5 ml/kg),最长4 h。结果:GYY4137预处理后存活率较对照组显著提高50% (p = 0.0025)。它还改善了高VT通气后的动脉氧合,肺动脉分压(PaO2)为64 mmHg (IQR 49-125 mmHg),对照组为44 mmHg (IQR 42-51 mmHg) (p T通气),其值为24 μl/cmH2O (IQR 22-27),而对照组为22 μl/cmH2O (IQR 22-24) (p = 0.017)。GYY4137对红系核因子2相关抗氧化基因表达影响最小,不影响谷胱甘肽代谢、核因子κ B途径或内质网应激反应。结论:GYY4137预处理对小鼠VILI模型具有保护作用。GYY4137显著提高生存率。它还改善了动脉血氧合和动态呼吸系统顺应性,减轻了肺水肿和炎症的发展。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Intensive Care Medicine Experimental
Intensive Care Medicine Experimental CRITICAL CARE MEDICINE-
CiteScore
5.10
自引率
2.90%
发文量
48
审稿时长
13 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信